RxDoctor Payments Data

Bradley Cook, MD

Family Medicine · Spokane Valley, WANPI 1770957854

Payments from drug & device makers

$297in general payments, 2019–2025

Across 10 payments — averaging $29.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axsome Therapeutics, Inc.$104
  • Abbott$45
  • Bard Peripheral Vascular, Inc.$30
  • Vapotherm Inc$28
  • Grifols USA, LLC$21
  • Lilly USA, LLC$20
  • plus $50 from 3 others

What the payments were for

  • Food & beverage$297100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$297 in reported general payments places this provider in the 70th percentile of 2,275 family medicine providers in Washington.

See all family medicine providers in Washington

Medicare billing

Part B allowed, 2024
$88,285
Medicare patients
224
Services billed
1,213

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban53$62,835
JardianceEmpagliflozin31$42,136
XareltoRivaroxaban20$34,206
OzempicSemaglutide19$33,550
Trelegy ElliptaFluticasone/Umeclidin/Vilanter33$28,770
Stiolto RespimatTiotropium Br/Olodaterol Hcl15$15,967
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen430$15,720
MounjaroTirzepatide12$14,753
Omeprazole220$4,402
Rosuvastatin Calcium353$4,052
Gabapentin140$4,024
Potassium Chloride134$3,967
Atorvastatin Calcium298$3,673
Alphagan PBrimonidine Tartrate16$3,360
Losartan Potassium322$3,170

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$19$33,55019 claims
Lilly USA, LLCMounjaro$20$14,75312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,275 family medicine providers in Washington.

Other family medicine in Spokane Valley

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →